Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Zi-Jian Xiang"'
Publikováno v:
Cancer Cell International, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Although people are more and more aware of the cardiotoxicity caused by immune checkpoint inhibitors (ICIs) in the treatment of lung cancer, its incidence rate has not been systematically analyzed. This study aims to evaluate the
Externí odkaz:
https://doaj.org/article/5cafcf72b602481ab2ab049fb1c76ea5
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: Invasive fungal infections (IFI) is an important contributing factor in morbidity and mortality of immunocompromised and critically ill patients. Although the therapeutic effects of these drugs on IFI have been well documented, the long-t
Externí odkaz:
https://doaj.org/article/5b17112f91944a4f980652bfafac5098
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 12 (2021)
Background: Chronic obstructive pulmonary disease (COPD) is characterized by persistent respiratory symptoms and dyspnea, as well as an increase in the number of leukocytes in the airways, lungs, and pulmonary vessels. A ‘One size fits all’ appro
Externí odkaz:
https://doaj.org/article/5ec229b2eb24474fb7080d03ea7f8e03
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 11 (2019)
Background: Adjuvant bisphosphonates reduce the rate of breast cancer recurrence in the bone and improve breast cancer survival. However, the risk of adverse events associated with bisphosphonate therapy for breast cancer remains poorly defined. Meth
Externí odkaz:
https://doaj.org/article/5f56c2f4bf86413e8e9f42388975c703
Publikováno v:
European Heart Journal. 41:4415-4422
Aims The aim of this study was to clarify the effect of β-blockers (BBs) on respiratory function and survival in patients with chronic obstructive pulmonary disease with cardiovascular disease (CVD), as well as the difference between the effects of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b2f318804e7ae9e9a4ba97ff2b4fe49
https://doi.org/10.1093/eurheartj/ehaa793
https://doi.org/10.1093/eurheartj/ehaa793
Publikováno v:
Annals of Palliative Medicine. 9:1782-1796
Background Lung cancer is the most common malignant tumor, and it remains the major cause of cancerrelated death worldwide. Anaplastic lymphoma kinase fusion gene-rearrangement (ALK-positive) nonsmall cell lung cancer (NSCLC) is a unique subgroup tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a0023355158e8e0c46b44fe3e94f9b3
https://doi.org/10.21037/apm-19-643
https://doi.org/10.21037/apm-19-643
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology
Frontiers in Pharmacology
Background: Invasive fungal infections (IFI) is an important contributing factor in morbidity and mortality of immunocompromised and critically ill patients. Although the therapeutic effects of these drugs on IFI have been well documented, the long-t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f53e5d2029e55bd9964b45c58cd37999
https://www.frontiersin.org/articles/10.3389/fphar.2021.697330/full
https://www.frontiersin.org/articles/10.3389/fphar.2021.697330/full
Publikováno v:
European heart journal. 42(34)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af752aaa728669ebc2341f6e57d5cbf7
https://pubmed.ncbi.nlm.nih.gov/33948644
https://pubmed.ncbi.nlm.nih.gov/33948644
Publikováno v:
Therapeutic Advances in Chronic Disease
Therapeutic Advances in Chronic Disease, Vol 12 (2021)
Therapeutic Advances in Chronic Disease, Vol 12 (2021)
Background: Chronic obstructive pulmonary disease (COPD) is characterized by persistent respiratory symptoms and dyspnea, as well as an increase in the number of leukocytes in the airways, lungs, and pulmonary vessels. A ‘One size fits all’ appro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc1671b68c37257726a3a1c16d28b171
https://pubmed.ncbi.nlm.nih.gov/34285789
https://pubmed.ncbi.nlm.nih.gov/34285789
Increase use of β-blockers in patients with chronic obstructive pulmonary and cardiovascular disease
Publikováno v:
European heart journal. 42(12)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6d62be25e9c77281543a9012b4b13c9
https://pubmed.ncbi.nlm.nih.gov/33495780
https://pubmed.ncbi.nlm.nih.gov/33495780